Health Care/Hospital
Ractigen Therapeutics Presents Positive First-in-Human Data for RAG-18 at WMS 2026, Establishing Clinical Proof-of-Mechanism for RNA Activation in Duchenne Muscular Dystrophy
* First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in human skeletal muscle in a monogenic disease. * Paired muscle biopsies reveal 3.5- to 5.3-fold increases in sarcolemmal utrophin expression,...
2026-10-03 19:30
3625
/DISREGARD RELEASE: Jiangsu Vcare/
We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire. ...
2026-10-02 19:12
4487
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that representatives from the Company's management and investor relations teams will participate in the 17th Annual Craig-Ha...
2026-10-02 18:30
3799
Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs
Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager Agreement also gives Novartis exclusive options to license other potential programs leveraging Abogen's RNA proprietary platform SUZHOU, China, Oct. 2, 2026 /PRNewswire/ -- Abogen Biosciences ("Abogen" or the ...
2026-10-02 12:42
2620
I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026"
PALO ALTO, Calif., Oct. 1, 2026 /PRNewswire/ -- I Peace Inc., a biotech company pioneering induced pluripotent stem cell (iPScell) technologies for regenerative medicine and longevity, today announced that it was selected as one of the awardees for the Top 10 Longevity Breakthrough Awards at the ...
2026-10-02 06:10
1416
Momcozy Announces $100,000 Scholarship Fund to Expand Access to Perinatal Mental Health Certification
LOS ANGELES, Oct. 1, 2026 /PRNewswire/ -- Momcozy, a leading global brand supporting women and families through pregnancy and motherhood, has partnered with Postpartum Support International (PSI) to establish a $100,000 scholarship fund designed to expand access to professional perinatal mental h...
2026-10-02 00:00
2691
Five Years of Purposeful Fashion: LILYSILK Renews Partnership with National Breast Cancer Foundation for 'A Bloom of Care' Campaign
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- LILYSILK, the world's leading silk brand
dedicated to inspiring people to live spectacularly, announced the renewal of
its partnership withNational Breast Cancer Foundation, Inc.® (NBCF)
2026-10-01 22:00
4703
Bambusa Therapeutics Initiates Subcutaneous Dosing of BBT001 in Atopic Dermatitis, Following Compelling Intravenous Proof-of-Concept Data
First patient dosed as Bambusa expands global development of its long-acting bispecific antibody targeting both IL-4Rα and IL-31 High-concentration subcutaneous formulation designed to combine BBT001's emerging profile of rapid, deep and durable clinical activity with convenient administration a...
2026-10-01 21:00
2569
Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency
* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...
2026-10-01 19:00
2462
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., Sept. 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform co...
2026-10-01 04:00
4962
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
* Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. * The development and manufacturing activities are being conducted at Piramal's dedicated sterile injectable facility in Lexington, Kentucky. * This partnership addresse...
2026-09-30 21:54
1615
Phrontline Biopharma Doses First Patient in Global Phase I/II Trial of TJ102, an FRα × CDH6 Bispecific Dual-Payload ADC
First clinical program built on Phrontline's DLP1 branched dual-payload linker platform HANGZHOU, China and SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Phrontline Biopharma, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), today announced that the f...
2026-09-30 21:53
1747
Yuyu Pharma Brings Ari's Purrfect to Amazon Accelerate 2026
Korean pharmaceutical company explores Amazon AI and seller tools to grow its U.S. feline-health brand SEOUL, South Korea, Sept. 30, 2026 /PRNewswire/ -- Robert Wonsang Yu, CEO of Yuyu Pharma (KRX: 000220), attended Amazon Accelerate 2026 in Seattle from September 22 to 24 to explore how Amazon'...
2026-09-30 21:00
1119
Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China
BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical
2026-09-30 20:00
1119
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI...
2026-09-30 20:00
1549
Zhongchao Inc. Announces 1-for-2 Share Consolidation
SHANGHAI, Sept. 30, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-2 share consolidation o...
2026-09-30 20:00
3310
EASD 2026 | Ecnoglutide Demonstrates Favorable Safety Profile in Adolescents with Obesity
HANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- At the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind") today announced that its Phase 1b randomized, double-blind, placebo-controlled study of ecnoglutide, the worl...
2026-09-30 19:00
1521
Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma
SEONGNAM, South Korea, Sept. 30, 2026 /PRNewswire/ -- Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion on the Orpha...
2026-09-30 17:33
932
Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
CAMBRIDGE, Mass., Sept. 30, 2026 /PRNewswire/ -- As population aging accelerates with demand for weight management continuing to expand, the market for GLP-1 receptor agonist (GLP-1RA) drugs is experiencing explosive growth. Tirzepatide, with annual sales of $36.507 billion in 2025, has become th...
2026-09-30 13:57
1061
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
* Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure. * With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province's leadership p...
2026-09-30 03:28
2670
Week's Top Stories
Most Reposted
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 281 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 267 media titles]
2026-09-30 10:50
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 267 media titles]
2026-10-01 10:00
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
22969
